Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Altria

The near-term future of CRON stock appears uncertain, but the relationship with Altria could make it succeed as a different type of equity.
The post Cronos Stock Will Benefit From Altria, but Only in the Distant Future appeared first on InvestorPlace.

Cronos Stock Will Benefit From Altria, but Only in the Distant Future

Cisco Systems

Walmart

Cronos Group, Cisco Systems, and Walmart can help parent investors pay for their child's sheepskin.

3 Stocks That Could Help You Send Your Kids to College: Cronos, Cisco & Walmart

Aurora Cannabis

Canopy Growth

HEXO Corp

Tilray Brands

The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.

Short Sellers - Get Even Higher on Cannabis Stocks

Cronos Group (CRON) closed at $15.43 in the latest trading session, marking a +0.39% move from the prior day.

Cronos Group (CRON) Gains But Lags Market: What You Should Know

Analysts say investors are underappreciating the balance-sheet strength of Canopy Growth and Cronos Group.

Cannabis News: Cash Is King

OrganiGram Holdings Inc.

Derivative cannabis products will soon hit licensed Canadian dispensaries.

Everything You Need to Know About Marijuana Legalization 2.0

Rapid sales growth yields no guarantee of profitability in the cannabis space.

Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?

Although CRON stock appears to be trading at a deep discount, prospective buyers should take into consideration the coming confluence of technical and fundamental headwinds.
The post I’m Glad I Don’t Own Cronos Group Stock and Here’s Why appeared first on InvestorPlace.

I’m Glad I Don’t Own Cronos Group Stock and Here’s Why

CannTrust Holdings

It always happens when there is a new kid on the block. The huge interest and momentum buying drives up shares as people hungry to get in pay more than they should for fear of missing out.

Huge Buying Opportunity in Marijuana Stocks as Short Sellers Pounce

Although CRON stock has held up better than some of its peers, sector volatility appears ready to take it down too.
The post Did Cronos Group Just Become a Big-Time Sell?

Did Cronos Group Just Become a Big-Time Sell?

The bloom is gone for the marijuana sector. Even the more conservative CRON stock is now feeling the side effects.

Even Cronos Isn’t Safe From the Pot Stock Implosion

The buzz is beginning to wear off for the most popular cannabis stocks.

7 Reasons Aurora, Canopy, Cronos, and HEXO Are All At or Near 6-Month Lows

Amplify Alternative Harvest ETF

Speculate on America's growing pot adoption with these marijuana ETFs.

Best Marijuana ETFs for Conservative Portfolios

Innovative Industrial Properties

Trulieve Cannabis Corp.

Despite supply and tax problems, some cannabis stocks are expected to make money this year.

10 Pure-Play Pot Stocks Forecast to Make Money in 2019

CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.
The post Cronos Needs to Show the Market Something to Pull Stock Out of Funk appeared first on InvestorPlace.

Cronos Needs to Show the Market Something to Pull Stock Out of Funk

Cronos (CRON) inks deal to acquire fermentation and manufacturing facility in Winnipeg, Canada, from Apotex Fermentation Inc.

Cronos to Acquire Apotex's Manufacturing Plant in Winnipeg

Aphria

GW Pharmaceuticals

Canadian cannabis companies have leapt onto U.S. stock markets, dazzling investors.

Mapping Out Canada's Cannabis Invasion Of The U.S.

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Get Even Higher on Cannabis Stocks.

Cronos is taking its time, which isn't a bad thing long-term. But it could be a near-term issue for CRON stock.

Cronos Isn’t in a Rush. Investors in Cronos Stock Shouldn’t Be Either

Cronos Group (NASDAQ: CRON) (TSX:CRON) announced Thursday it entered into an agreement to acquire GMP compliant fermentation and manufacturing facility from Apotex Fermentation.

Cronos Group Will Acquire GMP Compliant Fermentation, Manufacturing Facility

Canadian cannabis company Cronos Group Inc. CRON, -1.55% said Thursday it has agreed to acquire an 84,000 square foot fermentation and manufacturing facility in Winnipeg from Apotex Fermentation Inc.

Canadian cannabis company Cronos buying fermentation and manufacturing plant in Winnipeg

Cronos Group (NASDAQ: CRON) on Tuesday announced the appointment of Dr. Todd Abraham as the company's Chief Innovation Officer.

Cronos Group Names Todd Abraham As New Chief Innovation Officer

Scotts Miracle-Gro

Several economists and market researchers believe that the four  bills may pave the way for marijuana ETFs, which are likely to attract billions of dollars in investment.

5 Picks Ahead of Key Congressional Hearing on Marijuana Laws

Rapid sales growth won't save these popular pot stocks from another year of red ink.

Marijuana's "Big Four" Stocks Will Likely Lose Money in 2020

Add another marijuana stock to the exchange's lineup, and join the growing crowd ordering burritos at the popular Mexican fast-casual restaurant chain.

News for Cronos Group Stock (CRON)